Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FCN-437c Alone or With Letrozole in ER+/HER2- Advanced Breast Cancer
NCT04488107Phase 2Unknown
- Sponsor
- Jinzhou Ahon Pharmaceutical Co., Ltd.
- Start
- Feb 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ongiciclib in breast cancer, sponsored by Jinzhou Ahon Pharmaceutical Co., Ltd.. Status: unknown.
02
Drugs
ongiciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04488107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04488107.